Restricted mean survival time difference was 0.84 years at 10 years for women undergoing pulmonary resection
TUESDAY, Dec. 1, 2020 (HealthDay News) — Women undergoing pulmonary resection for lung cancer have an improved prognosis compared with men, according to a study published online Nov. 16 in Chest.
Erik Sachs, M.D., from the Karolinska University Hospital in Stockholm, and colleagues conducted a nationwide population-based observational cohort study to examine sex-specific survival after pulmonary resection for lung cancer among 6,356 patients. To account for differences in baseline characteristics, inverse probability of treatment weighting was used. The correlation between female sex and all-cause mortality was examined using Cox regression models.
The researchers found that the risk for death was lower for women than men (hazard ratio, 0.73). At one, five, and 10 years, the absolute survival difference was 3.0, 10, and 12 percent, respectively. At 10 years, the restricted mean survival time difference was 0.84 years. Across several subgroups, these findings were consistent.
“The health care sector is always striving to offer all patients equal treatment tailored to their individual needs,” Sachs said in a statement. “This kind of study can help shed light on systematic differences that ultimately affect patient outcomes.”
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy 
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes 
Gene Mutation Identified That Increases Lung Cancer Risk 
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Napping Opportunity May Improve Clinical Performance of Anesthesia Residents 
Disparities Identified in Home Health Care After Hip, Knee Replacement 
Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery 
.jpg)
